PACS
Overvalued by 408% based on the discounted cash flow analysis.
Market cap | $5.97 Billion |
---|---|
Enterprise Value | $6.50 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.75 |
Beta | 0 |
Outstanding Shares | 152,399,733 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 153.48 |
---|---|
PEG | -118.96 |
Price to Sales | - |
Price to Book Ratio | 4.25 |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | - |
Enterprise Value to Net Income | - |
Total Debt to Enterprise | 0.09 |
Debt to Equity | 1.06 |
No data
No data